| Trial ID: | L5401 |
| Source ID: | NCT01195259
|
| Associated Drug: |
Allocation Of Treatment With Metformin Or Rosiglitazone
|
| Title: |
Malignancy Meta Analysis for BRL49653
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: allocation of treatment with metformin or rosiglitazone
|
| Outcome Measures: |
Primary: Time to first occurrence of a serious adverse event of malignancy (excluding non-melanomatous skin cancers), ADOPT approximately 4 years duration, RECORD approximately 5.5 years duration |
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2009-10
|
| Completion Date: |
2010-01
|
| Results First Posted: |
|
| Last Update Posted: |
2013-10-28
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01195259
|
